Ποια είναι η τιμή για Entia Biosciences, Inc. (ERGO)

Η τιμή για Entia Biosciences, Inc. (ERGO) είναι $0.0002

Ποια είναι η κεφαλαιοποίηση αγοράς για Entia Biosciences, Inc. (ERGO)

Η κεφαλαιοποίηση αγοράς για Entia Biosciences, Inc. (ERGO) είναι $6.73K

Entia Biosciences, Inc. (ERGO) Τιμή και Κεφαλαιοποίηση Αγοράς

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.

Η τιμή για ERGO	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$159,933 $6.73K	NVDA	$5.383T	+79,966,717,962.98%
$131,414 $6.73K	AAPL	$4.423T	+65,706,939,943.64%
$123,600 $6.73K	GOOG	$4.160T	+61,799,901,847.15%
$108,833 $6.73K	MSFT	$3.663T	+54,416,530,455.56%
$85,895.09 $6.73K	AMZN	$2.891T	+42,947,545,880.39%

Η τιμή για ERGO

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$159,933 $6.73K